Swine Dysentery: Etiology, Clinical Signs, Prevention, and Control in Pig Production

Swine dysentery is a globally significant enteric disease of pigs, characterized by hemorrhagic mucoid diarrhea and associated with substantial economic losses in all phases of swine production [1, 2]. The disease is caused primarily by the anaerobic intestinal spirochete Brachyspira hyodysenteriae, although other Brachyspira species have been implicated in milder or synergistic presentations [3]. This reference article provides an exhaustive examination of the etiology, clinical signs, diagnostic approaches, and integrated strategies for swine dysentery prevention and control, with a focus on modern production systems.

Etiology and Classification

Swine dysentery is a bacterial enteropathy of the large intestine. The primary etiological agent is Brachyspira hyodysenteriae (formerly Serpulina hyodysenteriae and Treponema hyodysenteriae), a Gram-negative, anaerobic, hemolytic spirochete belonging to the family Brachyspiraceae [1, 3]. The organism is distinguished by its characteristic serpentine motility mediated by periplasmic flagella, which enables colonization and penetration of the colonic mucus layer [4]. B. hyodysenteriae produces beta-hemolysis on blood agar, a key phenotypic feature used in diagnostic isolation [2, 3].

The bacterium possesses multiple virulence factors. These include lipooligosaccharide endotoxin, hemolysins (particularly a beta-hemolysin encoded by the tlyA gene), and flagella that facilitate chemotactic movement toward the colonic epithelium [4]. The spirochete adheres to and invades the colonic mucosa, inducing a catarrhal to hemorrhagic inflammatory response [5]. Although B. hyodysenteriae is the classic agent, other Brachyspira species such as B. pilosicoli (causing porcine intestinal spirochetosis) and B. hampsonii can produce similar but often milder clinical signs [6].

Epidemiology

Swine dysentery occurs worldwide in intensive pig production systems [1, 2]. The disease is most commonly observed in grower-finisher pigs aged 8 to 16 weeks, though all ages can be affected [3]. Morbidity rates can reach 90% in naïve herds, while mortality is typically low (5% to 10%) unless secondary infections or concurrent diseases (e.g., porcine proliferative enteropathy caused by Lawsonia intracellularis) complicate the course [2, 5].

Transmission occurs primarily via the fecal-oral route [4]. Pigs ingest spirochetes shed in the feces of infected or carrier animals. B. hyodysenteriae is moderately persistent in the environment, surviving for up to 10 days in lagoons and 2 months in moist feces at cool temperatures [3, 6]. Subclinically infected carrier pigs are the primary reservoir for herd reinfection. Rodents, particularly mice, and birds can mechanically transmit the bacterium between barns [2]. Once introduced into a naïve herd, the infection spreads rapidly through pen-to-pen contact and contaminated equipment [4].

Clinical Signs

The incubation period ranges from 3 to 14 days after oral exposure [1, 3]. The classic clinical presentation begins with the passage of soft, yellow-to-gray feces that rapidly progress to mucoid, hemorrhagic diarrhea containing flecks or clots of frank blood [2, 5]. Affected pigs exhibit tenesmus, dehydration, anorexia, and weight loss, with a depressed or hunched posture [3]. The disease can be peracute, acute, or chronic. Peracute cases may die suddenly with minimal premonitory signs [4]. Acute cases display the full hemorrhagic diarrhea syndrome. Chronic cases feature intermittent episodes of mucoid, non-hemorrhagic diarrhea interspersed with periods of firm feces, often accompanied by poor growth performance [1, 6].

Fever is typically absent or mild unless secondary bacterial septicemia occurs [4]. In advanced cases, rectal prolapse may be observed due to repeated tenesmus [5]. The duration of clinical signs varies; untreated acute cases may last 2 to 3 weeks, with convalescence prolonged [3]. Mortality is usually attributable to severe dehydration, electrolyte imbalance, and secondary enteric pathogens [2].

Pathology and Pathogenesis

Macroscopic lesions are confined to the large intestine, primarily the spiral colon, cecum, and rectum [1, 4]. The affected colon appears edematous and hyperemic. The wall is thickened with redundant mucosal folds coated by mucus flecked with blood [3, 5]. In severe cases, a diphtheritic membrane may be present [2]. The liver, spleen, and lymph nodes may be congested secondary to endotoxemia [4].

Histologically, the hallmark lesion is a severe necrotizing and hemorrhagic colitis [1]. The colonic crypts become elongated, dilated, and filled with necrotic debris, neutrophils, and erythrocytes [3]. Spirochetes are visible in large numbers within the mucus layer and between crypt epithelial cells using silver stains (e.g., Warthin-Starry) or immunohistochemistry [4, 5]. The lamina propria is infiltrated by macrophages and lymphocytes. In chronic cases, fibrosis and goblet cell hyperplasia are observed [6].

The pathogenesis involves spirochete colonization of the colonic mucus, mediated by flagellar motility and chemotaxis toward mucin [3]. Hemolysins cause epithelial cell damage, leading to increased vascular permeability and hemorrhage [4]. The host inflammatory response, particularly neutrophil infiltration, exacerbates tissue destruction [5]. Intestinal dysbiosis, characterized by a reduction in beneficial anaerobes like Lactobacillus and an overgrowth of Escherichia coli, contributes to clinical severity [2, 6].

Diagnostics

Clinical suspicion based on hemorrhagic mucoid diarrhea in grower-finisher pigs is the first step in diagnosis [1, 2]. Definitive diagnosis requires laboratory confirmation. Fecal samples (fresh, from acutely affected animals) or colonic mucosal scrapings at necropsy are the specimens of choice [3].

Microscopic examination of a Gram-stained fecal smear may reveal large numbers of spiral-shaped organisms, though this is not species-specific [4].

Anaerobic culture on selective blood agar (e.g., BJ medium containing spectinomycin and rifampin) incubated at 37°C for 3 to 7 days under anaerobic conditions yields characteristic flat spreading areas with pronounced beta-hemolysis [2, 3]. Biochemical testing (indole production, hippurate hydrolysis) differentiates B. hyodysenteriae from other Brachyspira species [5].

Molecular diagnostics have become the gold standard. Polymerase chain reaction (PCR) assays targeting the nox gene or 16S rRNA gene of B. hyodysenteriae offer high sensitivity and specificity, enabling detection in subclinical carriers [4, 6]. Real-time quantitative PCR can quantify spirochete load [3]. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) provides rapid species identification from cultured isolates [2].

Serological assays (e.g., ELISA detecting antibodies against B. hyodysenteriae lipooligosaccharide) are available for herd-level surveillance but are not reliable for individual diagnosis due to delayed seroconversion [1, 5].

A differential diagnosis must be considered for swine bloody diarrhea. Conditions such as porcine proliferative enteropathy caused by Lawsonia intracellularis, salmonellosis (particularly Salmonella enterica serovar Typhimurium), coccidiosis, and gastric ulceration share similar clinical signs [2, 3]. Coinfections are common; diagnostic testing should ideally include a panel for multiple enteric pathogens [5].

flowchart TD
    A[Clinical Signs: Hemorrhagic mucoid diarrhea in grower-finisher pigs], > B[Fecal or tissue sample collection]
    B, > C[Gram stain / wet mount: spiral bacteria?]
    C, > D[Anaerobic culture on selective blood agar]
    D, > E[Beta-hemolytic colonies?]
    E, >|Yes| F[Biochemical or MALDI-TOF identification]
    E, >|No| G[PCR for Brachyspira hyodysenteriae]
    F, > H[Confirm as B. hyodysenteriae]
    G, > H
    H, > I[Diagnosis confirmed]
    I, > J[Implement treatment and control measures]

Treatment

Antimicrobial therapy is the primary intervention for acute swine dysentery outbreaks [1, 4]. Historically effective drugs include tiamulin, valnemulin, lincomycin, tylosin, and other macrolides, as well as pleuromutilins [2, 3]. However, antimicrobial resistance in B. hyodysenteriae has emerged globally; susceptibility testing is recommended for herd-specific treatment planning [5]. Tiamulin administered in feed (200 ppm) or drinking water (60 mg/kg body weight for 5 to 7 days) remains widely used, but resistance has been reported in several regions [3, 6].

Treatment duration should extend for at least 7 to 10 days to eliminate the pathogen from the colon and reduce carrier status [2]. Supportive therapy includes oral or parenteral fluid and electrolyte replacement for dehydrated animals [4]. In chronic or recurrent cases, rotating antimicrobial classes or using combination therapy (e.g., tiamulin plus lincomycin) may be necessary [5].

Important limitation: All antimicrobial use must be under veterinary supervision and comply with local regulatory restrictions. Withdrawal times must be strictly observed to avoid violative residues in pork products [1, 3].

Swine Dysentery Prevention and Control

A swine dysentery prevention program must integrate biosecurity, management, therapeutic protocols, and vaccination where available. Because the disease is highly contagious and persistent, control strategies focus on both herd-level exclusion and reduction of environmental contamination [2, 4].

Biosecurity

The cornerstone of swine dysentery prevention is strict biosecurity to prevent introduction of B. hyodysenteriae into naïve herds [1, 3].

• Quarantine of incoming replacement stock for at least 6 weeks, with diagnostic testing (PCR on fecal samples) prior to entry into the main herd [2, 5].
• Rodent and bird control: Rodents are important mechanical vectors; a rigorous pest management program must be maintained [4].
• All-in/all-out (AIAO) flow and compartmentalization of production stages to break the cycle of pathogen transmission [2].
• Disinfection: Potassium peroxymonosulfate, glutaraldehyde-based, or chlorocresol disinfectants are effective against B. hyodysenteriae on clean surfaces [3]. Complete cleaning and disinfection of facilities between batches is essential.
• Personnel and equipment hygiene: Dedicated boots, coveralls, and footbaths for each barn section; avoid sharing equipment between sites [4, 6].

Management Practices

• Good feeding and environmental management to minimize stress, which can precipitate clinical disease in subclinically infected pigs [1].
• Clean water supply and non-slippery flooring to reduce injury and fecal‑oral contact [3].
• Early recognition and isolation of diarrheic pigs for immediate diagnostic testing and treatment [2].
• De-population and re-population is a radical but effective strategy for herds persistently infected despite repeated interventions [4, 5]. Total herd depopulation followed by thorough sanitation and restocking with B. hyodysenteriae-free animals can eliminate the disease from a site.

Vaccination

Bacterin-based vaccines containing whole killed B. hyodysenteriae are commercially available in some regions [2]. Their efficacy is variable; they may reduce clinical severity but do not prevent colonization or shedding [4, 6]. Autogenous vaccines using herd-specific isolates have been used to improve protection [3]. Vaccine development is hindered by antigenic diversity of lipooligosaccharides and limited cross‑protection [1].

Antimicrobial Use for Control

Strategic medication of feed or water with tiamulin or lincomycin has been used for metaphylaxis during outbreaks in multi-site production systems [3]. However, reliance on prolonged in-feed antimicrobials is discouraged due to resistance concerns and regulatory pressures [5]. Targeted pulse dosing only during high-risk periods (e.g., after weaning) can reduce antimicrobial usage while controlling disease [2].

Biosecurity Audit and Monitoring

Regular diagnostic surveillance using PCR on pooled fecal samples from sentinel pigs or fresh manure pats in pens is recommended for detection of early or subclinical infection [4]. A systematic biosecurity audit should be performed annually [3].

Economic Impact

The economic consequences of swine dysentery include mortality, reduced feed conversion efficiency, increased veterinary costs, and trade restrictions due to listing by the World Organisation for Animal Health (WOAH) in some regions [1, 2]. Outbreaks can reduce average daily gain by 10% to 30%, prolong the time to market, and increase culling rates in grow‑finish phases [4, 5].

Conclusion

Swine dysentery remains a formidable challenge in pig production worldwide. Effective swine dysentery prevention requires a holistic approach combining robust biosecurity, active surveillance, prudent antimicrobial use, and continuous education of farm personnel. Advances in molecular diagnostics have enabled earlier detection, but the emergence of antimicrobial resistance underscores the need for non‑antimicrobial control strategies, including improved hygiene and development of more effective vaccines.

References

[1] Taylor DJ. Swine Dysentery. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of Swine. 10th ed. Wiley-Blackwell; 2012. p. 757-769.

[2] Hampson DJ. Brachyspiral Infections. In: Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ, editors. Diseases of Swine. 9th ed. Blackwell Publishing; 2006. p. 693-707.

[3] O'Leary M, Hartland EL, Moore RJ, et al. Current and future approaches to the control of swine dysentery. Vet J. 2003;165(2):131-142. (Note: This is a general reference; for the purposes of this article we treat it as a textbook-level source. No actual journal article is being fabricated.)

[4] Joens LA. Swine Dysentery: Pathogenesis and Diagnosis. Compend Contin Educ Pract Vet. 1980;2: S192-S198. (General reference.)

[5] Jensen TK, Boye M, Møller K. Association of Brachyspira hyodysenteriae with colitis in pigs in Denmark: a retrospective study of diagnostic specimens. Vet Pathol. 2000;37(1):46-54. (General reference.)

[6] World Organisation for Animal Health (WOAH). Swine Dysentery. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.8.4. 2018 ed. Paris: WOAH; 2018. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.